Concepedia

Ailiang Zeng

AZ

Statistics

Publications

28

Citations

2K

H-Index

23

Active since

2015

Affiliations

Nanjing Medical University(Current)

Jiangsu Province Hospital

Brigham and Women's Hospital

Harvard University

The University of Texas MD Anderson Cancer Center

Ailiang Zeng is an author at Nanjing Medical University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2015–2023

28

Publications

28

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma

Zhuoran Zhang, Jianxing Yin, Chenfei Lu et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 268 citations · Full text

, , +17

Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma

Jianxing Yin, Ailiang Zeng, Zhuoran Zhang et al. · EBioMedicine · 2019 · 208 citations · Full text

, , +16

Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma

Ailiang Zeng, Zhiyun Wei, Wei Yan et al. · Cancer Letters · 2018 · 190 citations

, , +16

miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas

Shouwei Li, Ailiang Zeng, Qi Hu et al. · Neuro-Oncology · 2016 · 125 citations · Full text

, , +17

Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p

Jianxing Yin, Xin Ge, Zhumei Shi et al. · Theranostics · 2020 · 114 citations · Full text

, , +17

1–5 of 28